Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies

The outbreak of the COVID-19 pandemic in China has become an urgent health and economic challenge. The objective of the current work was to evaluate the efficacy of the combined complex of Sitagliptin (SIT) with melittin (MEL) against SARS-CoV-2 virus. SIT-MEL nano-conjugates were optimized by a ful...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Al-Rabia, Mohammed W., Alhakamy, Nabil A., Ahmed, Osama A. A., Eljaaly, Khalid, Alaofi, Ahmed L., Mostafa, Ahmed, Asfour, Hani Z., Aldarmahi, Ahmed A., Darwish, Khaled M., Ibrahim, Tarek S., Fahmy, Usama A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8025909/
https://ncbi.nlm.nih.gov/pubmed/33652894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados